Thank you, Mr. Malo.
This is a changing process. It is very difficult to develop an HIV vaccine because of the effect of HIV on the immune system. If we manufacture a vaccine that produces a similar syndrome, that's a bad thing. The question of lowering immunity is a challenge all its own. It is always possible that a vaccine will have that effect with the experiments. We have to be sure that the vaccine is safe. This is very important.
The capacity to manufacture the vaccine has improved since the decision. That decision was the best one for the time. Good advice was given and good ideas provided, but the world has changed. Now, it is a challenge, a big challenge. It is wise to have the resources needed for developing an effective HIV vaccine. The other $82 million may make it possible to work on other aspects, not the...
bricks and mortar.
It is a big challenge for the scientific community. There is a possibility of a vaccine, but while we are waiting, there may be a lot of surprises.
Frank, do you have anything you want to add to that?
Or maybe it's back to you. You may have wanted to do another question.